# Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study

> **NCT05447559** · PHASE4 · RECRUITING · sponsor: **Monash University** · enrollment: 9180 (estimated)

## Conditions studied

- Surgical Site Infection

## Interventions

- **DRUG:** Cefazolin
- **DRUG:** Water for injection

## Key facts

- **NCT ID:** NCT05447559
- **Lead sponsor:** Monash University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-07
- **Primary completion:** 2027-12
- **Final completion:** 2028-06
- **Target enrollment:** 9180 (ESTIMATED)
- **Last updated:** 2026-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05447559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05447559, "Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT05447559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*